PASG logo

Passage Bio, Inc. Common Stock


PASG: Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.


Show PASG Financials

Consumer Interest
SEC Filings

Recent trades of PASG by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by PASG's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PASG in WallStreetBets Daily Discussion


Recent insights relating to PASG

CNBC Recommendations

Recent picks made for PASG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PASG

Corporate Flights

Flights by private jets registered to PASG